The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...

Using vertical fixation for implantable collamer lens placement may improve clinical outcomes, according to a study published ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...

The Afinity Collamer Aspheric foldable intraocular lens (Model CQ2015A) has been designated as a New Technology Intraocular Lens (NTIOL) by CMS, Staar Surgical announced. The approval for NTIOL ...

Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ...

Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but that paradigm has shifted with the advent of the EVO Visian implantable collamer lens.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...

The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...